Skip to main content
ASTAL LABORATORIES LIMITED logo

ASTAL LABORATORIES LIMITED — Investor Relations & Filings

Ticker · 512600 ISIN · INE307N01014 LEI · 8945004HO2WCBQ0CJ976 BSE.NS Manufacturing
Open in API
Filings indexed 445 across all filing types
Latest filing 2021-01-20 Regulatory Filings
Country IN India
Listing BSE.NS 512600

About ASTAL LABORATORIES LIMITED

https://miel.co.in/

Astal Laboratories Limited is a pharmaceutical organization engaged in the development, manufacturing, and marketing of a diverse range of pharmaceutical formulations. The company's product portfolio encompasses various dosage forms, including tablets, capsules, liquid orals, and topical preparations. It operates across several therapeutic categories, such as anti-infectives, analgesics, and gastrointestinal treatments. Astal Laboratories prioritizes quality control and adheres to established manufacturing standards to ensure the safety and efficacy of its products. The company focuses on providing accessible healthcare solutions through a robust distribution network and a commitment to research-driven formulation development.

Recent filings

Filing Released Lang Actions
Compliances -Certificate under Reg.74(5) of SEBI (DP) Reg.2018
Regulatory Filings Classification · 95% confidence The document is a confirmation certificate issued by a registrar and share transfer agent regarding compliance with SEBI regulations on dematerialization of securities for the quarter ended December 2020. It references regulatory compliance and confirmation of securities processing but does not contain financial statements, management discussion, or detailed financial data. The document length is short (1663 characters) and is primarily a regulatory confirmation letter. Therefore, it fits best under Regulatory Filings (RNS) as it is a compliance confirmation rather than a financial report or announcement of a report.
2021-01-20 English
Compliances - Certificate under Reg. 74(5) of SEBI (DP) Regulaions,2018
Regulatory Filings Classification · 95% confidence The document is a confirmation certificate related to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. It confirms the dematerialization of securities and related procedural compliance for the quarter ended December 2020. The document is a regulatory compliance confirmation and does not contain financial statements, management discussion, or report data. It is a certification letter from a registrar and share transfer agent to the company. Given the nature and length (1663 characters), it is not a full financial report or announcement but a regulatory filing confirming compliance with SEBI regulations. Therefore, the appropriate classification is Regulatory Filings (RNS).
2021-01-20 English
Closure of Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter from Macro International Limited addressed to the BSE Limited regarding the closure of the trading window. It references the SEBI (Prohibition of Insider Trading) Regulations and specifies the period during which trading in the company's equity shares will be restricted due to the upcoming announcement of unaudited financial results for the quarter and nine months ended 31 December 2020. The document does not contain any financial data, results, or detailed report content but is an announcement related to trading restrictions ahead of financial disclosures. It is a regulatory announcement about trading compliance rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS). The document length is short (1401 characters), and it is clearly an announcement rather than a report itself.
2020-12-30 English
Financial Result for Quarter ended & Half Yearly 30 Sep. 2020
Interim / Quarterly Report Classification · 95% confidence The document contains detailed unaudited standalone financial results for the quarter and six months ended 30th September 2020, including income statement figures, balance sheet data, and notes referencing compliance with SEBI regulations and Indian Accounting Standards. It includes actual financial data and analysis for a period shorter than a full fiscal year (quarter and half-year). The presence of comprehensive financial statements and management approval indicates this is an Interim / Quarterly Report rather than a brief announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2020-11-10 English
MACRO (INTERNATIONAL) EXPORTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2020 ,inter alia, to consider and approve Board Meeting ....
Regulatory Filings Classification · 95% confidence The document is a notice from Macro International Limited to the stock exchange (BSE Limited) informing about a scheduled Board Meeting to consider and take on record the unaudited financial results for the quarter and half year ended 30th September 2020. It references compliance with SEBI regulations and mentions the closure of the trading window due to insider trading regulations. The document does not contain the financial results themselves but is an announcement of the upcoming board meeting where these results will be considered. The document length is short (1795 characters) and it is clearly an intimation or announcement rather than the actual financial report. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement and compliance notice rather than an Interim/Quarterly Report (IR) or Earnings Release (ER).
2020-11-02 English
Certificate under Regulation 40(9) for Half Year ended 30th Sep. 2020
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 40(9) of the Listing Obligation and Disclosure Requirements Regulation, 2015, for the half year ended 30th September 2020. It is a compliance certificate from a practicing company secretary regarding share transfer activities (or lack thereof) during the period. The document is addressed to the stock exchange and is a regulatory compliance filing rather than a financial report or announcement of financial results. It does not contain financial statements or management discussion, nor is it an announcement of voting results or capital changes. It is primarily a certification related to regulatory compliance. Therefore, it fits best under Regulatory Filings (RNS). The document length is short (2720 characters), and it is a certificate, not a full report or announcement of a report publication.
2020-10-21 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.